HGH Fragment 177–191 is a peptide derived from the C-terminal region of human growth hormone and has been investigated primarily for effects related to lipid metabolism. Preclinical research has explored mechanisms involving adipose tissue and fatty-acid metabolism. However, robust human clinical evidence remains limited, and it is not an established approved treatment for weight management or athletic performance.